At LEMMO Integrated Cancer & Care Centre, we provide a diverse range of intravenous therapies.
We also focus on supporting the immune system and oxygen-based therapies, organs (i.e. liver), and a diverse list of medicines and natural-based agents used which may also be considered alongside a person’s conventional treatment program.
-
Amino Acids
-
Artesunate
-
Chelation (DMPS, EDTA)
-
Curcumin
-
DCA (dichloroacetate)
-
DMSO (dimethyl sulfoxide)
-
Glutathione
-
Hydrogen Peroxide
-
Fats / Lipids Intravenous
-
Lipoic Acid (ALA)
-
Methylene Blue
-
Mistletoe
-
MSM
-
Myer’s Cocktail
-
NAD+
-
Nutrition (vitamin, mineral, fats, etc.)
-
Ozone Therapy
-
Quercetin Intravenous
-
Ultraviolet Blood Irradiation
-
Intravenous Medical Laser Therapy
-
Vitamin C (ascorbate)
Studies & further reading
Selected publications for patients who want to explore the research. Each finding applies to the study’s own population, protocol and stage of evidence; your care team can help you understand what may be relevant to you.
This randomized study evaluated a specific intravenous curcumin formulation alongside paclitaxel in advanced metastatic breast cancer. The reported response findings encourage further confirmation with the same formulation and treatment context.
This case report describes extended survival in one person receiving an individualized programme that included intravenous alpha-lipoic acid and low-dose naltrexone. It offers a clinical observation that can inform future research.
This review discusses how critical illness can affect micronutrient status and how assessment may guide care. It supports an individualized, laboratory-informed approach rather than assuming the same infusion is suitable for everyone.
This real-world pilot compared the tolerability and administration experience of intravenous NAD+ and nicotinamide riboside. It offers early practical information for future prospective study.